Eventide Asset Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.6M Sell
479,098
-513
-0.1% -$32.6K 0.52% 66
2025
Q4
$30.5M Buy
479,611
+309,503
+182% +$19.3M 0.48% 77
2025
Q3
$9.35M Sell
170,108
-79,392
-32% -$3.27M 0.15% 131
2025
Q2
$8.24M Sell
249,500
-133,196
-35% -$4.63M 0.14% 131
2025
Q1
$15.4M Buy
382,696
+128,548
+51% +$5.91M 0.31% 98
2024
Q4
$12M Hold
254,148
0.22% 127
2024
Q3
$13.4M Hold
254,148
0.23% 106
2024
Q2
$13.8M Hold
254,148
0.24% 111
2024
Q1
$17.8M Sell
254,148
-301,852
-54% -$23.3M 0.28% 99
2023
Q4
$46.4M Hold
556,000
0.76% 45
2023
Q3
$16.4M Hold
556,000
0.29% 95
2023
Q2
$18.1M Hold
556,000
0.31% 89
2023
Q1
$19.6M Hold
556,000
0.36% 86
2022
Q4
$25.5M Buy
+556,000
New +$23.9M 0.5% 64

Other funds holding CYTK